Hope for Patients Suffering From Multiple Sclerosis

spcblog, 09 June 2017, No comments
Categories: Medical Practitioner

The NIAID, which is part of the National Institutes of Health sponsored the HALT-MS, a trial study on patients suffering from MS. The study kicked off in December 2014, and the results surfaced online in February 2017 in the renowned medical journal of the American Academy of Neurology. According to the results, there is evidence that a patient’s central nervous system can be affected by their immune system, upon an infestation of the autoimmune disease. According to researchers, the latter is caused when a patient is exposed to a high dosage of immunosuppressive therapy and by having their blood-forming cells transplanted.

 

According to research conducted, 69 percent of trial patients that had undergone both hematopoietic cell transplant and immunosuppressive therapy did not inhibit any signs of disability, new brain lesions or relapse of MS symptoms. According to other studies conducted, the MS drug has proven to have a low success level.

 

According to Anthony S. Fauci, NIAID Director, the reports state that a one-off treatment using HDIT/HCT could turn out to be more effective than some of the long-term methods being used by patients. He continues to say that the outcome could be a positive sign to carry out an examination to compare standard care and HDIT/HCT.

 

Some of the symptoms of MS include body weakness, fatigue, severe pain, and difficulty in speech. However, the most common symptom exhibited in most patients is relapsing. At one point during the trial study, 24 patients between the ages of 26 and 52 years volunteered to undergo a test to establish the effectiveness and safety of HDIT/HCT. However, despite being under severe medication, the patients experienced severe inflammation.

 

According to researchers, the treatment is aimed at destroying the stubborn disease cells and restoring a patient’s immune system. Despite positive results from the study patients, experts say that they need to conduct more study on the treatment method. According to Richard Nash, who served as the key investigator during the study, he says that the end-results of the study proof that the treatment could be what scientist have been seeking to find.

 

About Dr. Shiva Gopal Vasishta

 

Dr. Shiva Gopal Vasishta is a renowned neurologist based in Voorhees, New Jersey. In the year 1979, Dr. Shiva Gopal Vasishta enrolled for his studies in the Government Medical College. He brings to the table over 40 years of experience and skills in the field.

 

Dr. Shiva Gopal Vasishta finished his residency at the famous Boston City Hospital. Dr. Shiva Gopal Vasishta is also a licensed psychiatrist and currently offers his esteemed services at Eastern Neurodiagnostic Associates.

Comments

Leave a Reply:

Name *

Mail (hidden) *

Website